Digital Breast Tomosynthesis is Transforming Mammography
Digital breast tomosynthesis (DBT) equipment is revolutionizing mammography by providing better detection and diagnosis of breast cancer. With DBT technology, physicians can create a 3D-like image from multiple X-ray exposures taken from different angles around the breast. This provides the clearest and most complete picture yet to help accurately identify abnormalities that may indicate breast cancer. The benefits of DBT over digital mammography include increased diagnostic accuracy which helps reduce callback rates and the number of unnecessary biopsies, especially in women with dense breasts.
The global digital breast tomosynthesis equipment market is estimated to be valued at US$ 750 million in 2025 and is expected to exhibit a CAGR of 15% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the digital breast tomosynthesis equipment are Hologic Inc., Siemens Healthcare Private Limited, PLANMED OY, Carestream Health, FUJIFILM Holdings Corporation. Hologic Inc. captured over 65% market share in 2020 owing to its innovative SecurView DX-D and Dimension platform solutions.
The growing awareness about early breast cancer detection and benefits of DBT over digital mammography is fueling the demand for DBT equipment globally. Various government initiatives promoting screening and support for affordable DBT systems will further support the market growth.
Leading players are focusing on emerging markets through acquisitions and partnerships to gain geographic foothold. For instance, Hologic acquired SuperSonic Imagine to strengthen its DBT product portfolio and global footprint in 2021.
Market Key Trends
One of the key trends gaining traction in the digital breast tomosynthesis equipment market is the development of multi-modality imaging solutions integrated with MRI, ultrasound and mammography. Players are launching hybrid systems offering complementary imaging modalities to improve diagnostic power. For example, Hologic launched Panther Fusion in 2020, the first system providing tomosynthesis, digital breast tomosynthesis and contrast-enhanced spectral mammography in one exam.
The increasing replacement demand for older digital mammography systems with advanced DBT solutions is also supporting the market growth. Integration of AI and machine learning capabilities is another emerging trend helping radiologists with automated tools for reviewing images efficiently.
Porter's Analysis
Threat of new entrants: Low upfront investments required however significant technical expertise and skills are required. Bargaining power of buyers: Higher as there are a few large healthcare providers dominating the global market. Bargaining power of suppliers: Moderate level owing to the availability of substitute production methods for components. Threat of new substitutes: Moderate threat as new and advanced medical imaging technologies are emerging. Competitive rivalry: High level due to presence of majority market share held by top global players. North America accounts for the largest share of the digital breast tomosynthesis equipment market owing to increasing incidents of breast cancer and growing awareness. The region has seen steady adoption of digital breast tomosynthesis equipment due to supportive government reimbursement policies and increasing healthcare expenditures.
Asia Pacific region is poised to witness the highest growth during the forecast period owing to rising healthcare infrastructure, growing medical tourism, and increasing healthcare spending in emerging countries such as China and India. Large untapped population base and improving access to diagnostic services will further support market growth in the Asia Pacific region.
Get this Report in Japanese Language: デジタル乳房トモシンセシス装置市場
Get this Report in Korean Language: ぢ 기타 l B 희귀 st 모두 syn s s
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
